🇺🇸 FDA
Patent

US 10113183

Adeno-associated virus vectors for treatment of glycogen storage disease

granted A61KA61K48/0008A61K48/005

Quick answer

US patent 10113183 (Adeno-associated virus vectors for treatment of glycogen storage disease) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K48/0008, A61K48/005, A61K48/0066, A61K48/0075